LOW vs MAZE · P/E 18, rev $86.29B vs $525.3M cap
Lowe's Companies Inc (LOW) versus Maze Therapeutics, Inc. Common Stock (MAZE) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Maze Therapeutics, Inc. Common Stock (MAZE) is a biotechnology company listed on US.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported MAZE revenue for 2025-06-30 was $0. Net income was -$66.5M. Revenue was down 100.0% from 2024-09-30 to 2025-06-30. MAZE currently screens at market cap $525.3M.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. MAZE currently screens at market cap $525.3M.
Not investment advice. Open the LOW and MAZE stock pages for the full models.
Not investment advice.